Scott Weiss: Population Studies, Biobanks, and Arrays

October 21, 2016

Scott Weiss, MD, MS, discusses his work in genetic association studies using Illumina microarrays. http://www.illumina.com/techniques/microarrays.html Dr. Weiss highlights why array quality and accuracy is so critical in asthma genetics research. He shares how the genotyping data in their biobank is helping partner investigators identify variants and take their studies to the next level. Researcher: Scott Weiss, MD, MS Scientific Director of Partners HealthCare Personalized Medicine, Associate Director, Channing Laboratory of Brigham and Women's Hospital A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina product videos https://www.youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd View Illumina support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM

Share this article on